Jean-Frédéric Colombel - Université Lille 1
ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well
Jean-Frederic Colombel (@JeanFredericCo1) / X
IBD Research at Mount Sinai - Dr. Jean-Frédéric Colombel, from the Feinstein IBD Clinical Center and Department of Gastroenterology at Mount Sinai Hospital, is featured as our first IBD expert! Read his
Dr. Jean-Frederic Colombel, MD - Gastroenterology Specialist in New York, NY | Healthgrades
Meet the Study Team | Peter Laboratory
New drugs are 'nice' but many IBD questions remain open for study | MDedge Internal Medicine
AIBD 2022
Sherman Prize - Congratulations Dr. Jean-Frederic Colombel of Mount Sinai who receives the $100K Sherman Prize for leading breakthroughs in understanding IBD genetics, risk factors and optimal treatment approaches. Read more https://bit.ly/2O9Blab
Jean-Frederic Colombel, MD | The Sherman Prize
Jean-Frederic Colombel - Gastroenterology | Mount Sinai - New York
Key for IBD: Early Diagnosis and Prevention with Jean-Frederic Colombel - YouTube
Targeting Disease Prediction and Prevention: The New Frontier in IBD
Dr. Jean-Frederic Colombel, MD, Gastroenterology | New York, NY | WebMD
We are LIVE with Dr. Jean-Frederic Colombel and Dr. James Marion as they discuss the Mount Sinai 15th Annual IBD Consultant's Course on October 12! Visit... | By The Mount Sinai Hospital
Jean-Frederic Colombel, ECCO-IBD 2022: Upadacitinib in Ulcerative Colitis: Results from the UPA Phase 3 Programme - touchIMMUNOLOGY
Jean-Frederic Colombel, ECCO 2023: A sub-analysis investigating upadacitinib for rapid symptom relief in Crohn's disease - touchIMMUNOLOGY
Congratulations to our 2024 Research Mentor Award recipients - American Gastroenterological Association
Advancing therapies for IBD
Targeting Disease Prediction and Prevention: The New Frontier in IBD
